Stay updated on Skin bioMARkers for Atopic Eczema Therapy Evaluation Clinical Trial
Sign up to get notified when there's something new on the Skin bioMARkers for Atopic Eczema Therapy Evaluation Clinical Trial page.

Latest updates to the Skin bioMARkers for Atopic Eczema Therapy Evaluation Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.0%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe webpage has been updated to reflect a new clinical trial focusing on the safety of crisaborole (2%) ointment compared to betamethasone valerate (0.1%) cream for atopic dermatitis, with specific details about the study's design and collaborators. Notably, the previous aims and methodologies related to assessing safety biomarkers have been removed.SummaryDifference34%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
- Check66 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.8%
- Check88 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.8%
Stay in the know with updates to Skin bioMARkers for Atopic Eczema Therapy Evaluation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Skin bioMARkers for Atopic Eczema Therapy Evaluation Clinical Trial page.